[
  {
    "ts": "2025-11-27T15:10:00+00:00",
    "headline": "Follicular Lymphoma Market Trends, Opportunities, Growth Challenges and Competitive Intelligence 2025-2035",
    "summary": "The global follicular lymphoma market is witnessing growth due to advancements in targeted therapies and immunotherapies. Follicular lymphoma, an indolent form of non-Hodgkin lymphoma, often presents challenges like relapse and treatment resistance, underscoring the need for novel treatment strategies. Innovative therapies such as monoclonal antibodies and CAR T-cell therapies are enhancing patient outcomes by providing more precise and less toxic options compared to traditional chemotherapy. Ke",
    "url": "https://finance.yahoo.com/news/follicular-lymphoma-market-trends-opportunities-151000804.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "33e56308-30ec-3804-a349-931dc4d70c4f",
      "content": {
        "id": "33e56308-30ec-3804-a349-931dc4d70c4f",
        "contentType": "STORY",
        "title": "Follicular Lymphoma Market Trends, Opportunities, Growth Challenges and Competitive Intelligence 2025-2035",
        "description": "",
        "summary": "The global follicular lymphoma market is witnessing growth due to advancements in targeted therapies and immunotherapies. Follicular lymphoma, an indolent form of non-Hodgkin lymphoma, often presents challenges like relapse and treatment resistance, underscoring the need for novel treatment strategies. Innovative therapies such as monoclonal antibodies and CAR T-cell therapies are enhancing patient outcomes by providing more precise and less toxic options compared to traditional chemotherapy. Ke",
        "pubDate": "2025-11-27T15:10:00Z",
        "displayTime": "2025-11-27T15:10:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc",
          "originalWidth": 480,
          "originalHeight": 58,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_MlAqEncKPaKK77zrkRGmQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 480,
              "height": 58,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/caWFqk489OEmv3xI33JamQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/follicular-lymphoma-market-trends-opportunities-151000804.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/follicular-lymphoma-market-trends-opportunities-151000804.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-27T14:45:00+00:00",
    "headline": "AstraZeneca or Merck: Which Oncology Giant Has the Edge?",
    "summary": "AZN and MRK boast major oncology strengths and expanding pipelines amid shifting market dynamics in this pharma matchup.",
    "url": "https://finance.yahoo.com/news/astrazeneca-merck-oncology-giant-edge-144500891.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "b95f3303-1aa3-31d1-b5d5-3a0ed1e23e90",
      "content": {
        "id": "b95f3303-1aa3-31d1-b5d5-3a0ed1e23e90",
        "contentType": "STORY",
        "title": "AstraZeneca or Merck: Which Oncology Giant Has the Edge?",
        "description": "",
        "summary": "AZN and MRK boast major oncology strengths and expanding pipelines amid shifting market dynamics in this pharma matchup.",
        "pubDate": "2025-11-27T14:45:00Z",
        "displayTime": "2025-11-27T14:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/65d4d9838ddb692fbe578219ce60c69d",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OAiu5He0SiZzKJ7weu9Org--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/65d4d9838ddb692fbe578219ce60c69d.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xHxlTKesMnS_SkMo1hl1jw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/65d4d9838ddb692fbe578219ce60c69d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/astrazeneca-merck-oncology-giant-edge-144500891.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/astrazeneca-merck-oncology-giant-edge-144500891.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "AZN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-27T14:00:05+00:00",
    "headline": "Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know",
    "summary": "Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finance.yahoo.com/news/investors-heavily-search-merck-co-140005749.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8d1c846c-69c6-350d-a5c5-34c4d23894b2",
      "content": {
        "id": "8d1c846c-69c6-350d-a5c5-34c4d23894b2",
        "contentType": "STORY",
        "title": "Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know",
        "description": "",
        "summary": "Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
        "pubDate": "2025-11-27T14:00:05Z",
        "displayTime": "2025-11-27T14:00:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1",
          "originalWidth": 900,
          "originalHeight": 602,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tLc26fx9TJ6VqGsh8AFf8w--~B/aD02MDI7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1.cf.webp",
              "width": 900,
              "height": 602,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G.EHzHXMwORhvPQ5KT6TdQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/investors-heavily-search-merck-co-140005749.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/investors-heavily-search-merck-co-140005749.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]